Arkansas center focused on improving prevention and treatment for food allergies
Arkansas Center for Food Allergy Research (ArCOFAR)
This center will work to create better prevention and treatment options for children and adults with food allergies, including peanut allergy and tick‑related alpha‑gal syndrome.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arkansas Children's Hospital Res Inst NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-11283973 on NIH RePORTER |
What this research studies
At Arkansas Children's Hospital, this center will run clinical studies and trials aimed at improving how food allergies are prevented and treated. If you join, researchers will enroll children and adults—especially people from rural and underserved communities—and collect health information and biological samples to learn what helps. The team brings over 30 years of experience with peanut immunotherapy and eosinophilic gastrointestinal disorders and will include patients with alpha‑gal syndrome common in the region. Their work is intended to translate study findings into treatments and prevention options that could be used more widely.
Who could benefit from this research
Good fit: Children and adults with food allergies—such as peanut allergy, eosinophilic gastrointestinal disorders, or suspected alpha‑gal syndrome—or those at high risk who can travel to Arkansas or nearby CoFAR sites are ideal candidates.
Not a fit: People without food allergies or with health issues unrelated to allergic disease are unlikely to receive direct benefits from this center's work.
Why it matters
Potential benefit: If successful, this work could produce new prevention strategies and more effective treatments for food allergies and improve access for rural and underserved patients.
How similar studies have performed: Related efforts like peanut immunotherapy have shown promising results, though prevention strategies and work on conditions like alpha‑gal and EGID remain an active area of research.
Where this research is happening
Little Rock, United States
- Arkansas Children's Hospital Res Inst — Little Rock, United States (Active)
Researchers
- Principal investigator: Jones, Stacie M — Arkansas Children's Hospital Res Inst
- Study coordinator: Jones, Stacie M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.